Pharmacology, Toxicology and Pharmaceutical Science
Rifampicin
100%
Combination Therapy
88%
Staphylococcus Aureus
83%
Antibiotics
70%
Ciprofloxacin
62%
Infection
58%
Antiinfective Agent
53%
Daptomycin
45%
Graft Infection
44%
Methicillin-Resistant Staphylococcus Aureus
44%
Rat Model
44%
Antibiotic Agent
44%
Mitomycin
44%
Antimicrobial Resistance
44%
Vancomycin
28%
Synergism
11%
Drug Discovery
11%
Cytotoxicity
11%
Mortality Rate
11%
Absence
11%
High-Throughput Screening
11%
Survival Rate
11%
Antibiotic Therapy
11%
Bacterial Infection
8%
Infectious Agent
8%
Azo Reductase
8%
Monotherapy
5%
Therapeutic Effect
5%
Buffer
5%
Fosfomycin
5%
Immunology and Microbiology
Staphylococcus Aureus
100%
Biofilm
59%
Rat Model
44%
Toxin-Antitoxin System
44%
Cell Adhesion
44%
Listeria monocytogenes
44%
Methicillin-Resistant Staphylococcus Aureus
44%
Restriction Modification System
44%
Bacteriophage
44%
Antimicrobial Activity
44%
Antimicrobial Resistance
44%
Infectious Agent
37%
Antibiotic Sensitivity
37%
Listeria
22%
Cell Level
22%
Synergism
22%
Cytotoxicity
14%
Survival Rate
14%
Mortality Rate
14%
Minimum Inhibitory Concentration
14%
High Throughput Screening
14%
Chemical Structure
14%
Colony Forming Unit S
14%
Bacterial Growth
14%
Excision Repair
14%
Whole Genome Sequencing
14%
Bacterial Load
11%
Bactericidal Activity
11%
Growth Inhibition
11%
Metabolism
11%
Keyphrases
High-throughput Assay
44%
Persister Cells
44%
Adaptive Laboratory Evolution
44%
Anti-persister
26%
MqsA
22%
MqsR
22%
Rifampicin Resistance
17%
Minimal Media
9%
Exponential Phase
9%
Nongrowing
9%
Antimicrobial Pressure
8%
Resistance Shift
8%
Antibiotic Misuse
8%
Prolonged Antibiotics
8%
Long-term Evolution Experiment
8%
Dormant State
7%
Phage DNA
7%
Mechanisms of Programmed Cell Death
7%
Anti-phage
7%
McrBC
7%
Phage Inhibition
7%
Phage Propagation
7%
